Loading
Lille pulmonologist and thoracic oncologist who presides over the IFCT, France's academic lung cancer trials group.
Alexis Cortot is President of the Intergroupe Francophone de Cancérologie Thoracique (IFCT), elected at the June 2025 general assembly. He is a pulmonologist at Lille University Hospital whose research covers targeted therapy and immunotherapy for non-small cell lung cancer. The IFCT runs multicentre academic trials in thoracic oncology across France and francophone countries.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer, clinical trials.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer, clinical trials.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.